Financial Daily from THE HINDU group of publications
Friday, Feb 08, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Industry & Economy - Pharmaceuticals


Drug price control order `sketchy'

Our Bureau

MUMBAI, Feb. 7

THE Indian pharmaceutical industry is still unclear on the drug price control order (DPCO). Top officials of leading pharma companies said that things are sketchy as to what the final list of drugs coming under price control will be.

Mr M.K. Hamied, Director, Cipla Ltd told Business Line that apart from the price control, issues such as research and development benefits are still unclear.

"These issues are very crucial not only for Cipla but also the Indian industry keeping in mind the post-2005 scenario,'' he said. Other industry watchers said that most Indian companies would not be affected as they have a business strategy in place keeping in mind the DPCO.

"Most Indian companies have the choice of introducing drugs or new molecules and thereby bringing down the exposure to the DPCO to a minimal. However, multinational companies do not have that luxury,'' an industry watcher said.

Analysts said that MNCs such as Glaxo, Pfizer and EMerck would benefit immensely going by the criteria laid out by the policy.

Send this article to Friends by E-Mail

Stories in this Section
Dumping duty on paracetamol recommended


FIs, banks seek redefinition of interest exemptions
Pay hikes seen hitting rock bottom: Survey
Chambers for more reforms
New tech to cut power station emissions
`Corporate sector must have role in eco development'
US keen on closer trade ties
India, Russia sign protocol for economic co-operation
Free trade urged
Hotels post 60 pc drop in forex earnings
Swiss pharma cos seek IPR protection
Drug price control order `sketchy'
Bitter challenges of a free market
Govt relief for more textile mill workers
SSIs to get MDA support for bar-coding registration
A school for Cyberabad's elite
Specialty Ranbaxy seeks norms for pathological labs
Tanners face uncertainty as relocation deadline nears
A swap deal worth trying?
Nasscom signs MoU with Italian association
Insat-3C at home
Price bids for Paradeep Phos today
`Stronger global IPRs will impact foreign investment'
Narrowing the digital divide in rural areas
`Quality in agro-products key to develop exports'


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line